Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Neven Papic"'
Publikováno v:
Infectious Disease Reports, Vol 14, Iss 3, Pp 420-427 (2022)
Healthcare associated meningitis and ventriculitis (HCAMV) are serious complications of neurosurgical procedures. We conducted a retrospective cohort study of patients with HCAMV treated at the University Hospital for Infectious Diseases Zagreb durin
Externí odkaz:
https://doaj.org/article/31fbb35a86bf4ca5826d2bc6fd06aa5f
Publikováno v:
Biomedicines, Vol 11, Iss 10, p 2786 (2023)
Semaphorins have recently been recognized as crucial modulators of immune responses. In the pathogenesis of COVID-19, the activation of immune responses is the key factor in the development of severe disease. This study aimed to determine the associa
Externí odkaz:
https://doaj.org/article/a268437f919b4ee2996a81ac4c11ebec
Publikováno v:
Microorganisms, Vol 11, Iss 6, p 1571 (2023)
Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in Western countries, has been identified as a possible risk factor for COVID-19 severity. However, the immunological mechanisms by which NAFLD exacerbates COVID-19
Externí odkaz:
https://doaj.org/article/a5d49e2a90574164822bc74360a1dabd
Autor:
Neven Papic, Leona Radmanic, Davorka Dusek, Ivan Kurelac, Snjezana Zidovec Lepej, Adriana Vince
Publikováno v:
Infectious Disease Reports, Vol 12, Iss 3, Pp 74-81 (2020)
Late presentation to care is the major obstacle to receiving treatment for chronic hepatitis C (CHC). Our aim was to analyze the prevalence and trends of late presenters (LP) at first consultations in Croatia during a 10-year period. This retrospecti
Externí odkaz:
https://doaj.org/article/5f3b79ea00b84fa7b2114835ca4e4983
Autor:
Neven Papic, Lara Samadan, Nina Vrsaljko, Leona Radmanic, Karlo Jelicic, Petra Simicic, Petra Svoboda, Snjezana Zidovec Lepej, Adriana Vince
Publikováno v:
Life, Vol 12, Iss 6, p 795 (2022)
Non-alcoholic fatty liver disease (NAFLD) is identified as a risk factor for developing severe COVID-19. While NAFLD is associated with chronic low-grade inflammation, mechanisms leading to immune system hyperactivation remain unclear. The aim of thi
Externí odkaz:
https://doaj.org/article/856c676f3ef444c6834d13dd1cf7651b
Autor:
Adriana Vince, Neven Papic
Publikováno v:
Infectious Disease Reports, Vol 10, Iss 1 (2018)
not available
Externí odkaz:
https://doaj.org/article/747e475e17a04354a6b53d6de9d20958
Autor:
Neven Papic, Snjezana Zidovec Lepej, Lana Gorenec, Ivana Grgic, Slavko Gasparov, Tajana Filipec Kanizaj, Adriana Vince
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209481 (2018)
Semaphorins are a diverse family of immunoregulators recently recognized to play a major role in various phases of immune responses. Their role in chronic viral hepatitis C (CHC) and contribution to the progression of liver disease is unknown. The ai
Externí odkaz:
https://doaj.org/article/8b39784ef9044d4f97c0409f80264ed9
Autor:
Bret S. E. Heale, Shuanghu Liu, Don A. Delker, Neven Papic, Christopher I. Maxwell, Curt H. Hagedorn
Publikováno v:
Viruses, Vol 4, Iss 4, Pp 581-612 (2012)
We describe the first report of RNA sequencing of 5' capped (Pol II) RNAs isolated from acutely hepatitis C virus (HCV) infected Huh 7.5 cells that provides a general approach to identifying differentially expressed annotated and unannotated genes th
Externí odkaz:
https://doaj.org/article/21c063c461194364902b8cd85a1566aa
Autor:
Amina A Negash, Hilario J Ramos, Nanette Crochet, Daryl T Y Lau, Brian Doehle, Neven Papic, Don A Delker, Juandy Jo, Antonio Bertoletti, Curt H Hagedorn, Michael Gale
Publikováno v:
PLoS Pathogens, Vol 9, Iss 4, p e1003330 (2013)
Chronic hepatitis C virus (HCV) infection is a leading cause of liver disease. Liver inflammation underlies infection-induced fibrosis, cirrhosis and liver cancer but the processes that promote hepatic inflammation by HCV are not defined. We provide
Externí odkaz:
https://doaj.org/article/610a0f9d2d424d2eb943af8e8bfe3521
Alveolar echinococcosis is an emerging zoonotic disease caused by the parasite Echinococcus multilocularis. Most patients are diagnosed at a late stage, when lifelong treatment with benzimidazoles is required to stop disease progression. However, for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e12f00df952b24e100bb849cf9d54e99
https://doi.org/10.4269/ajtmh.22-0465
https://doi.org/10.4269/ajtmh.22-0465